Records containing: Oligodendrogliomas
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-11-22Phase II Trial of LB100, a Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma
-
CLINICAL_TRIALS study record update · 2023-01-31Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas
-
CLINICAL_TRIALS study record update · 2022-12-29PI3K/mTOR Pathway Activation Selected Phase II Study of Everolimus (RAD001) With and Without Temozolomide in the Treatment of Adult Patients With Supratentorial Low-Grade Glioma
-
CLINICAL_TRIALS study record update · 2022-02-03Clinical Development of MR Spectroscopy and Imaging in Brain Cancers
-
CLINICAL_TRIALS study record update · 2014-08-05Treatment Strategy for Low-grade Gliomas
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-08-30Research of Molecular and Metabolic Diagnostic Markers in Oligodendrogliomas A and B Comparatively.